
1. j immunol. 2012 feb 15;188(4):1905-14. doi: 10.4049/jimmunol.1101978. epub 2012
jan 11.

il-12rβ2 essential development experimental cerebral malaria.

fauconnier m(1), palomo j, bourigault ml, meme s, szeremeta f, beloeil jc,
danneels a, charron s, rihet p, ryffel b, quesniaux vf.

author information: 
(1)immunologie et embryologie moléculaires, centre national de la recherche
scientifique, 45071 orléans, france.

a th1 response required development plasmodium berghei anka
(pba)-induced experimental cerebral malaria (ecm). role pro-th1 il-12 in
malaria complex controversial. study, addressed role of
il-12rβ2 ecm development. c57bl/6 mice deficient il-12rβ2, il-12p40, or
il-12p35 analyzed ecm development blood-stage pba infection in
terms ischemia blood flow noninvasive magnetic resonance imaging and
angiography, cell recruitment, gene expression. without il-12rβ2, no
neurologic sign ecm developed upon pba infection. although wild-type mice
developed distinct brain microvascular pathology, ecm-resistant,
il-12rβ2-deficient mice showed unaltered cerebral microcirculation the
absence ischemia pba infection. contrast, mice deficient il-12p40
or il-12p35 sensitive ecm development. resistance of
il-12rβ2-deficient mice ecm correlated reduced recruitment activated t
cells impaired overexpression lymphotoxin-α, tnf-α, ifn-γ brain
after pba infection. therefore, il-12rβ2 signaling essential ecm
development independent il-12p40 il-12p35. document novel link 
between il-12rβ2 lymphotoxin-α, tnf-α, ifn-γ expression, key cytokines
for ecm pathogenesis.

doi: 10.4049/jimmunol.1101978 
pmid: 22238458  [indexed medline]

